Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
US Army
Baxter
Chubb
Mallinckrodt
Express Scripts
UBS
Deloitte
Moodys

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,829,088

« Back to Dashboard

Summary for Patent: 4,829,088
Title: Medicament for the treatment of inflammations of the eye
Abstract:The invention relates to an ophthalmic medicament containing diclofenac-sodium in aqueous solution. Owing to the addition of a specific stabilizer, the medicament has excellent stability against chemical decomposition of the active ingredient and outstanding preservation properties and is tolerated very well by the eye.
Inventor(s): Doulakas; Johann (Winterthur, CH)
Assignee: Dispersa AG (Hettlingen, CH)
Application Number:07/038,316
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound;

Drugs Protected by US Patent 4,829,088

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,829,088

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3612537Apr 14, 1986

International Patents Family Members for US Patent 4,829,088

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1286225 ➤ Subscribe
Germany 3612537 ➤ Subscribe
Denmark 164639 ➤ Subscribe
Denmark 176487 ➤ Subscribe
Egypt 18268 ➤ Subscribe
European Patent Office 0242328 ➤ Subscribe
Spain 2038691 ➤ Subscribe
Greece 3002659 ➤ Subscribe
Hong Kong 1394 ➤ Subscribe
Japan 2515788 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
Boehringer Ingelheim
Dow
US Army
US Department of Justice
McKesson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot